COSM Cosmos Health
- 0.6101
- +0.0932+18.03%
Cosmos Health News
Cosmos Health | 8-K: Entered Into A Rights Agreement
Cosmos Health | 8-K: Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
Cosmos Health | NT 10-K: Others
Cosmos Health | 8-K: Cosmos Health Receives a Non-Compliance Letter from Nasdaq and Company Defines Policies and Procedures for Related Party Transactions
Cosmos Health | S-3: Registration statement for specified transactions by certain issuers
Cosmos Health | 8-K: Cosmos Health Announces Acquisition of Licenses and Rights to 10 Generic Drugs for €3.2 Million
Cosmos Health | 8-K/A: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement (Amendment)
Cosmos Health | 8-K: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement
Cosmos Health | 8-K: Cosmos Health Board of Directors Adopted a Executive Compensation Clawback Policy
Cosmos Health | 8-K: Cosmos Health Reports Q3 2023 Results
Cosmos Health | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Cosmos Health | 8-K: CEO Issues Letter to Shareholders
Cosmos Health | 8-K: Current report
Cosmos Health | 8-K: Pavlos Ignatiades Chief Communications Officer Resignation and Poll Results of 2023 Annual Meeting of Shareholders
Cosmos Health | 8-K: Cosmos Health Announced Its Fiscal 2026 EBITDA Guidance
Cosmos Health | DEF 14A: Definitive information statements
Cosmos Health | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Cosmos Health | S-3: Registration statement for specified transactions by certain issuers
Cosmos Health | 8-K: Cosmos Health Announces Financial Results for the Second Quarter of 2023
Cosmos Health | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Analysis
Price Target
No Data
